COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 1168: Articles 11671-11680  | Next

Impact of biologics and small molecules for Inflammatory Bowel Disease on COVID-19 Related Hospitalization: A Systematic Review and Meta-analysis
Alrashed, F., Alasfour, H., Shehab, M.
10.1101/2021.10.24.21265344 — Posted: 2021-10-26
Geographical inequalities in the evolution of the COVID-19 pandemic: An ecological study of inequalities in mortality in the first wave and the effects of the first national lockdown in England
Welsh, C. E., Albani, V., Matthews, F. E., Bambra, C.
10.1101/2021.10.23.21265415 — Posted: 2021-10-26
Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil
Gilson Silva, A. V. F., Menezes, D., Moreira, F. R. R., Torres, O. A., Fonseca, P. L. C., Moreira, R. G., Alves, H. J., Alves, V. R., Amaral, T. M. d. R., Coelho, A. N., Saraiva-Duarte, J. M., da Rocha, A. V., de Almeida, L. G. P., de Araujo, J. L. F., de Oliveira, H. S., de Oliveira, N. J. C., de Sa, C. Z., de Souza, J. H., de Souza, E. G., de Souza, R. M., Ferreira, L. d. L., Gerber, A. L., Guimaraes, A. P. d. C., Maia, P. H. S., Marim, F. M., Miguita, L., Monteiro, C. C., Saliba Neto, T., Pugedo, F. S. F., Queiroz, D. C., Cuzzuol Queiroz, D. N. A., Resende-Moreira, L. C., Santos, F. M., Souza, E. F. C., Voloch, C. M., Vasconcelos, A. T., Aguiar, R. S. d., Souza, R. P. d.
10.1101/2021.10.21.21265140 — Posted: 2021-10-26
Use of serology immunoassays for predicting SARS-CoV-2 infection: a serology-based diagnostic algorithm
Lazo-Langner, A., Chin-Yee, B., Tong, J., Lowes, L., Hedley, B. D., Silverman, M., Delport, J., Bhayana, V., Knauer, M., Chin-Yee, I.
10.1101/2021.10.23.21265429 — Posted: 2021-10-26
Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection
Tamanaha, E., Zhang, Y., Tanner, N.
10.1101/2021.10.25.465706 — Posted: 2021-10-25
Disease waves of SARS-CoV-2 in Iran closely mirror global pandemic trends
Fattahi, Z., Mohseni, M., Beheshtian, M., Jafarpour, A., Jalalvand, K., Keshavarzi, F., Behravan, H., Ghodratpour, F., Zare Ashrafi, F., Kalhor, M., Azad, M., Koshki, M., Ghaziasadi, A., Soveyzi, M., Abdollahi, A., Kiani, S. J., Ataei-Pirkooh, A., Rezaeiazhar, I., Bokharaei-Salim, F., Haghshenas, M. R., Babamahmoodi, F., Mokhames, Z., Soleimani, A., Elahi, Z., Ziaee, M., Javanmard, D., Ghafari, S., Ezani, A., AnsariMoghaddam, A., Shahraki-Sanavi, F., HashemiShahri, S. M., Azaran, A., Yousefi, F., Moattari, A., Moghadami, M., Fakhim, H., Ataei, B., Nasri, E., Poortahmasebi, V., Varshochi, M., Mojtahedi, A., Jalilian, F., Khazeni, M., Moradi, A., Tabarraei, A., Piroozmand, A., Yahyapour, Y., Bayani, M., Tavangar, F., Yaghoubi, M., Keramat, F., Tavakoli, M., Jalali, T., Pouriayevali, M. H., Salehi-Vaziri, M., Khorram Khorshid, H. R., Najafipour, R., Malekzadeh, R., Kahrizi, K., Jazayeri, S. M., Najmabadi, H.
10.1101/2021.10.23.21265086 — Posted: 2021-10-25
The 1968 Influenza Pandemic and COVID-19 Outcomes
Taylor, C. A., Boulos, C., Memoli, M. J.
10.1101/2021.10.23.21265403 — Posted: 2021-10-25 Discussion: Onsite
COVID-19 breakthrough infections and pre-infection neutralizing antibody
Yamamoto, S., Maeda, K., Matsuda, K., Tanaka, A., Horii, K., Okudera, K., Takeuchi, J. S., Mizoue, T., Konishi, M., Ozeki, M., Sugiyama, H., Aoyanagi, n., Mitsuya, H., Sugiura, W., Ohmagari, N.
10.1101/2021.10.20.21265301 — Posted: 2021-10-25
Vaccine hesitancy for coronavirus SARS-CoV-2 in North India
Srivastav, U., Tripathi, A. K., Kaur, J., Devi, S., Verma, S., Singh, V., Das, D., Singh, P. P., Kumar, P., Rai, V., Pandey, R., Chaubey, G.
10.1101/2021.10.24.21265455 — Posted: 2021-10-25
Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
Funakoshi, Y., Yakushijin, K., Ohji, G., Hojo, W., Sakai, H., Takai, R., Nose, T., Ohata, S., Nagatani, Y., Koyama, T., Kitao, A., Nishimura, M., Imamura, Y., Kiyota, N., Harada, K., Tanaka, Y., Mori, Y., Minami, H.
10.1101/2021.10.25.21265324 — Posted: 2021-10-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).